Sector consensus Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:59 12/03/2026 GMT			5-day change	1st Jan Change
120.84 ^CHF	-0.33%		-3.19%	+10.26%

03:11pm	Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research	RE
10:23am	Mesoblast Limited Appoints Dr. Teresa Montagut As Head Of Clinical Development And Medical Affairs	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
NOVARTIS AG	CHF 151.21	-2.7%	21
ELI LILLY AND COMPANY	US$1,216.93	+21.71%	29
JOHNSON & JOHNSON	US$238.29	-1.93%	24
ABBVIE INC.	US$248.86	+9.3%	29
ROCHE HOLDING AG	CHF 364.79	+10.54%	19
ASTRAZENECA PLC	GBX 220	+13.32%	21
MERCK & CO., INC.	US$127.22	+9.48%	27
AMGEN INC.	US$350.03	-7.31%	29
GILEAD SCIENCES, INC.	US$156.59	+7.26%	27
NOVO NORDISK A/S	DKK 332.13	+32.96%	22
PFIZER INC.	US$28.43	+4.12%	26
VERTEX PHARMACEUTICALS INCORPORATED	US$546.26	+10.94%	27
BRISTOL-MYERS SQUIBB COMPANY	US$62.36	+3.97%	25
GSK PLC	GBX 20.32	-1.63%	20
SANOFI	€98.49	+29.16%	23
CHUGAI PHARMACEUTICAL CO., LTD.	JP¥9,823.33	+3.79%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	JP¥5,590.2	-2.85%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	CN¥82.39	+47.57%	17
BAYER AG	€44.94	+12.31%	20
Average	1,036.99	+10.53%	23
Weighted average by Cap.	691.7	+10.09%	25